Shen Leilei, Yun Tianyang, Guo Juntang, Liu Yang, Liang Chaoyang
Department of Thoracic Surgery, Hainan Hospital of General Hospital of PLA, Sanya 572000, China.
Department of Thoracic Surgery, General Hospital of PLA, Beijing 100853, China.
Nan Fang Yi Ke Da Xue Xue Bao. 2020 Dec 30;40(12):1793-1798. doi: 10.12122/j.issn.1673-4254.2020.12.14.
To analyze the clinicopathological characteristics and risk factors of 4L lymph node metastasis in left non-small cell lung cancer.
We retrospectively analyzed the data of 134 patients undergoing surgical resection of left non-small cell lung cancer and 4L lymph node dissection, including 60 patients with squamous cell carcinoma (SCC) and 74 with lung adenocarcinoma (ADC). The clinicopathological characteristics of the patients were analyzed, and logistic regression analysis was used to identify the predictors of station 4L metastasis.
Of these patients, 16.4% (22/134) presented with station 4L metastasis. The patients with SCC and ADC showed significant differences in age, gender, smoking history, neoadjuvant chemotherapy, tumor size, tumor location and type, visceral pleural invasion, Ki-67 index, 4L metastasis and pathological TNM stage (stage Ⅱ). The rate of station 4L metastasis was significantly lower in SCC group than in ADC group. Univariate analysis revealed that pathological types (SCC or ADC), visceral pleural invasion, lymphovascular invasion, tumor markerabnormality, and station 5 to 10 metastasis were all high-risk factors for station 4L metastasis. Multivariate analysis suggested that the pathological type (OR=0.120, =0.025), station 5 metastasis (OR=18.784, =0.007) and station 10 metastasis (OR=5.233, =0.044) were independent risk factors for 4L metastasis in patients with left non-small cell lung cancer.
In patients with left non-small cell lung cancer, station 4L metastasis is not rare and is more likely to occur in patients with lung adenocarcinoma. Dissection of the 4L lymph nodes should be performed in cases with low risk of damages of the adjacent tissues and high risk of station 4L metastasis.
分析左肺非小细胞肺癌4L组淋巴结转移的临床病理特征及危险因素。
回顾性分析134例行左肺非小细胞肺癌手术切除及4L组淋巴结清扫患者的数据,其中鳞癌(SCC)60例,肺腺癌(ADC)74例。分析患者的临床病理特征,并采用逻辑回归分析确定4L组转移的预测因素。
这些患者中,16.4%(22/134)出现4L组转移。SCC组和ADC组患者在年龄、性别、吸烟史、新辅助化疗、肿瘤大小、肿瘤位置及类型、脏层胸膜侵犯、Ki-67指数、4L组转移及病理TNM分期(Ⅱ期)方面存在显著差异。SCC组4L组转移率显著低于ADC组。单因素分析显示,病理类型(SCC或ADC)、脏层胸膜侵犯、脉管侵犯、肿瘤标志物异常及5~10组转移均为4L组转移的高危因素。多因素分析提示,病理类型(OR=0.120,=0.025)、5组转移(OR=18.784,=0.007)及10组转移(OR=5.233,=0.044)是左肺非小细胞肺癌患者4L组转移的独立危险因素。
左肺非小细胞肺癌患者中,4L组转移并不少见,且更易发生于肺腺癌患者。对于邻近组织损伤风险低且4L组转移风险高的病例,应行4L组淋巴结清扫。